Centessa Pharmaceuticals plc

NASDAQ:CNTA

13.17 (USD) • At close July 1, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 1500006.913000000000000000
Kosten van de omzet 0.2180.22800.2360.240.2480.2370.2380.090.0360.0350.0320.0280.012000.0020000
Brutowinst 14.8400-0.236-0.246.664-0.237-0.238-0.09-0.036-0.035-0.032-0.0280.015-0.0130-0.0020000
Brutowinstmarge 0.98900000.964000000000000000
Onderzoek- en ontwikkelingskosten 33.44372.92133.90332.81522.63929.97528.1933.67332.82627.83536.74453.65136.85345.46225.8518.13410.7790.9942.5741.8713.333
Algemene en administratieve kosten 12.33413.70612.50211.16513.43812.31512.01913.34616.05113.76812.28414.76314.38512.98812.46411.8415.7160.3080.1930.2580.383
Verkoop- en marketingkosten 0000-0.248-0.141000000000000000
Verkoop-, algemene en administratieve kosten 12.33413.95412.50211.16513.1912.17412.01913.34616.05113.76812.28414.76314.38512.98812.46411.8415.7160.3080.1930.2580.383
Overige kosten 01.53700-1.537-0.878-1.677-1.527-1.346-0.07-3.1435.3590.1960.23500-2.1411.703-0.6510-0.524
Bedrijfskosten 45.77774.5846.40543.9835.8342.14840.20947.01948.87741.60349.02868.41451.23854.52238.31429.97519.0193.1842.0382.1392.925
Bedrijfsresultaat -30.777-74.58-46.405-43.98-36.09-35.178-40.209-47.019-48.877-41.603-49.028-68.414-53.218-58.292-38.314-41.287-19.021-3.005-2.116-2.129-3.192
Bedrijfsresultaat ratio -2.0520000-5.089000000000000000
Totaal overige inkomsten en kosten netto 6.039-35.6994.4470.869-1.475-0.515-1.265-1.918-1.16-2.234-4.9883.731-1.2-2.368-1.841-0.164-221.267-0.281-0.022-0.0990.181
Inkomen voor belasting -24.738-110.279-42.388-43.159-37.544-36.003-41.474-48.937-50.491-43.837-54.016-64.683-54.418-60.66-40.155-41.451-240.288-3.286-2.138-2.228-3.011
Inkomen voor belasting ratio -1.6490000-5.208000000000000000
Belastingkosten 1.3971.050.6080.7050.4811.154-2.826-24.0510.677-0.664-0.141-0.0220.080.114-0.065-11.33900-0.022-0.0990.181
Nettowinst -26.135-111.329-42.566-43.816-38.024-37.157-38.648-24.886-50.714-43.173-53.875-64.661-54.498-60.774-40.155-41.451-240.288-3.286-2.138-2.228-3.011
Nettowinstmarge -1.7420000-5.375000000000000000
WPA (Winst Per Aandeel) -0.2-0.84-0.37-0.4-0.38-0.38-0.4-0.26-0.53-0.45-0.57-0.69-0.6-0.68-0.45-0.65-2.75-0.22-0.01500
Verwaterde WPA -0.2-0.84-0.37-0.4-0.38-0.38-0.4-0.26-0.53-0.45-0.57-0.69-0.6-0.68-0.45-0.65-2.75-0.22-0.01500
EBITDA -21.644-106.573-39.165-40.35-34.796-32.877-38.695-46.25-47.603-41.637-52.059-62.998-52.89-58.212-39.962-41.287-240.237-3.003-0.022-0.0990.181
EBITDA ratio -1.4430000-4.756000000000000000